SPEC — SpectraCure AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK68.41m
- SEK46.30m
- SEK1.53m
Annual income statement for SpectraCure AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.1 | 5.74 | 2.94 | 2.84 | 1.53 |
| Cost of Revenue | |||||
| Gross Profit | 7.45 | 7.13 | 5.99 | 12.4 | 11.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 20.4 | 29.1 | 28.7 | 24.2 | 24.6 |
| Operating Profit | -15.3 | -23.3 | -25.7 | -21.4 | -23.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -15.4 | -23.3 | -25.4 | -20.5 | -23 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -15.4 | -23.3 | -25.4 | -20.4 | -23 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.4 | -23.3 | -25.4 | -20.4 | -23 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.4 | -23.3 | -25.4 | -20.4 | -23 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.071 | -0.102 | -0.111 | -0.09 | -0.101 |
| Dividends per Share |